
Shares of Eli Lilly and Company (NYSE:LLY) are trading higher on Wednesday. The company said that its Zepbound drug was more effective in helping adults with obesity lose weight than Novo Nordisk A/S's (NYSE:NVO) Wegovy. It cited data from a phase 3b trial.
But the rally may be short-lived. This is why Eli Lilly is our Stock of the Day.